By Tyler Jacob, Marketing Manager Let’s cut through the noise: the future of medical and robotics innovation isn’t in flashy AI demos or trillion-dollar ...

A look at a device claimed to achieve perpetual motion, exploring its design, mechanics, and the science behind why it’s considered impossible. Belarus' president brings Kim Jong Un bizarre gift from ...

Add Yahoo as a preferred source to see more of our stories on Google. María Isabel is always on the go. Over the past year, the singer-songwriter has been living out of a suitcase, shuttling between ...

“The Young and the Restless” star Melissa Claire Egan recently revealed that she had been diagnosed with coronary heart disease. The 44-year-old shared the news on Instagram in late February, ...

Melissa Claire Egan is speaking out about a serious health scare. The longtime Young and the Restless actor revealed she has been diagnosed with coronary heart disease at 44. She said she chose to go ...

Heart disease is expected to spike over the next 25 years among younger women, according to a new warning from the American Heart Association. Doctors at Jefferson Einstein Hospital are now using an ...

Melissa Claire Egan revealed that she was diagnosed with heart disease. On Thursday, Feb. 26, The Young and the Restless star, 44, posted a photo on Instagram to share her health update and emphasize ...

Abiomed has issued an urgent medical device correction for its Impella RP and Impella RP Flex series of heart pumps. In a letter sent to customers on January 27, Abiomed said the voluntary device ...

CVRx, Inc. (NASDAQ: CVRX) on Thursday initiated the BENEFIT-HF clinical trial, a landmark randomized study supported by CMS Category B IDE coverage and designed to evaluate the impact of Barostim in a ...

CINCINNATI (WKRC) - Breakthrough technology is transforming the lives of local heart failure patients, offering new hope and improved quality of life. The TriHealth Heart and Vascular Institute is at ...

Penumbra expected to generate $1.4 bln in 2025 sales; shares surge 12% Transaction values Penumbra at $374 per share, 19.3% premium to last close Penumbra CEO Adam Elsesser to join Boston Scientific's ...

Boston Scientific said on Thursday it will buy ⁠medtech firm Penumbra in a deal valued at about $14.5 billion to expand its portfolio of cardiovascular devices, in the largest acquisition by the ...